One thing is evident, Europeans ought to learn more about the free market pricing of generics in the US – tenders, discounting and reference pricing don’t work. One can make the argument that same applies in the branded pharmaceutical marketplace.
A review of generic medicine pricing in Europe
Generics and Biosimilars Initiative Journal (GaBI Journal). 2012;1(1):8-12.
“The penetration of generic medicines is more successful in countries that permit free pricing of medicines than in those that have price regulation. Although tendering systems may reduce (generic) medicine prices in the short term, little is known about the overall long-term impact of such systems.”
The rest of the story can be found here.
Also, see here for a related story in the Pink Sheet.
Michael Moore, are you listening?
A review of generic medicine pricing in Europe
Generics and Biosimilars Initiative Journal (GaBI Journal). 2012;1(1):8-12.
“The penetration of generic medicines is more successful in countries that permit free pricing of medicines than in those that have price regulation. Although tendering systems may reduce (generic) medicine prices in the short term, little is known about the overall long-term impact of such systems.”
The rest of the story can be found here.
Also, see here for a related story in the Pink Sheet.
Michael Moore, are you listening?
